pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,990 catalysts · 3,350 8k filing · 1,368 grant · 1,000 device adverse event · 615 approval · 582 earnings · 476 device 510k

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 0 catalysts2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2026-02-24×clear all
type
  • 8k filing3,350
  • grant1,368
  • device adverse event1,000
  • approval615
  • earnings582
  • device 510k476
device pma
297
  • phase 2 completion172
  • drug shortage133
  • recall121
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Mar 9, 2026

    50
    ›Mar 10, 2026device pma159d agoCardiovascular Systems, Inc. — Diamondback 360™ Coronary Orbital Atherectomy System; Diamondback 360 Precision™ Coronary Orbital Atherectomy System (PMA supplement)

    Supplement type: 30-Day Notice. Product code: MCX. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Mar 10, 2026device recall159d agoSiemens Medical Solutions USA, Inc device recall (Cls II)

    ARTIS pheno and ARTIS Icono biplane, floor and ceiling. Model Numbers 10849000, 11327600, 11328100, 11327700. — Reason: During patient examinations, the system may sporadically display a major increase of the x-ray dose applied to the patient. Despite the reported dose showing significantly higher, the actual applied x-ray dose levels are in accordance with the system settings and imaging conditions, as well as the applicable regulatory requirements. — Status: Ongoing

    full page →fda device recalls ↗
    ›Mar 10, 2026grant159d agoUNIVERSITY OF TENNESSEE HEALTH SCI CTR — Extended amygdala somatostatin role in post-traumatic stress and alcohol use ...

    AA grant. $249,000. PI: Bryan Cruz

    full page →nih reporter ↗
    ›Mar 10, 2026grant159d agoBOSTON CHILDREN'S HOSPITAL — Developing Cognitive Control and Metacognition to Reduce the Functional Impac...Boston Children's Hospital

    MH grant. $990,550. PI: Susan Faja

    full page →nih reporter ↗
    ›Mar 10, 2026grant159d agoHENRY FORD HEALTH + MICHIGAN STATE UNIVERSITY HEALTH SCIENCES — Transgenic Access to Semilunar Granule of the Dentate Gyrus

    MH grant. $431,750. PI: Michael Roland Williams

    full page →nih reporter ↗
    ›Mar 10, 2026grant159d agoBRIGHAM AND WOMEN'S HOSPITAL — Using genomic modifiers to mechanistically link clonal hematopoiesis of indet...Brigham and Women's Hospital

    HL grant. $249,000. PI: Tetsushi Nakao

    full page →nih reporter ↗
    ›Mar 10, 2026grant159d agoNEW YORK UNIVERSITY — Data-driven modeling of molecular mechanisms underlying cellular quiescenceNew York University

    GM grant. $421,737. PI: Sarah Kostinski

    full page →nih reporter ↗
    ›Mar 10, 2026grant159d agoUNIVERSITY OF CALIFORNIA, SAN FRANCISCO — Molecular and functional dissection of prefrontal-hippocampal long-range inhi...University of California San Francisco

    MH grant. $800,384. PI: Vikaas Singh Sohal

    full page →nih reporter ↗
    ›Mar 10, 2026grant159d agoUNIVERSITY OF CALIFORNIA LOS ANGELES — Predicting Pediatric Postoperative Complications using Waveform and Electroni...University of California Los Angeles

    EB grant. $174,861. PI: Theodora E Wingert

    full page →nih reporter ↗
    ›Mar 10, 2026grant159d agoDANA-FARBER CANCER INST — Elucidating the Origins and Drivers of Clonal Dynamics in Hematopoiesis

    HL grant. $445,000. PI: Sahand Hormoz

    full page →nih reporter ↗
    ›Mar 10, 2026grant159d agoUNIVERSITY OF PITTSBURGH AT PITTSBURGH — Complement resistance and acute lung injury during Klebsiella pneumoniae infe...

    HL grant. $53,507. PI: Nathalie Chen

    full page →nih reporter ↗
    ›Mar 10, 2026grant159d agoWEILL MEDICAL COLL OF CORNELL UNIV — AlphaFold-Assisted Affinity Probe Resource for Scalable Brain Protein Mapping...

    MH grant. $1,611,088. PI: Zhuhao Wu

    full page →nih reporter ↗
    ›Mar 10, 2026grant159d agoUNIVERSITY OF WISCONSIN-MADISON — Revealing the role of vimentin in adult mouse hippocampal neurogenesis

    NS grant. $415,717. PI: Darcie Leann Moore

    full page →nih reporter ↗
    ›Mar 10, 2026grant159d agoUNIVERSITY OF PENNSYLVANIA — Molecular Timekeepers: Converging Pathways in Circadian ControlUniversity of Pennsylvania

    GM grant. $487,287. PI: Akhilesh Basi Reddy

    full page →nih reporter ↗
    ›Mar 10, 2026grant159d agoUNIVERSITY OF DELAWARE — Modules to improve the quality of the mentor-mentee working relationship

    GM grant. $94,154. PI: Lisa Jaremka

    full page →nih reporter ↗
    ›Mar 10, 2026grant159d agoYALE UNIVERSITY — Regulation of infant social behaviors and learning by the zona incerta

    MH grant. $838,378. PI: Marcelo Dietrich

    full page →nih reporter ↗
    ›Mar 10, 2026grant159d agoWEILL MEDICAL COLL OF CORNELL UNIV — Transcriptional control by autism associated H3K9 methylation regulators duri...

    MH grant. $800,667. PI: Matthias Stadtfeld

    full page →nih reporter ↗
    ›Mar 10, 2026grant159d agoDANA-FARBER CANCER INST — The Fourth International Merkel Cell Carcinoma Symposium

    AR grant. $20,000. PI: Ann W. Silk

    full page →nih reporter ↗
    ›Mar 10, 2026grant159d agoDREXEL UNIVERSITY — Investigating molecular mechanisms of glutamate toxicity in HIV-1 Tat-induced...

    MH grant. $49,416. PI: Brenna Duffy

    full page →nih reporter ↗
    ›Mar 10, 2026grant159d agoDUKE UNIVERSITY — Functions and mechanisms of metalloenzymes in natural product and cofactor bi...Duke University

    GM grant. $737,152. PI: Kenichi Yokoyama

    full page →nih reporter ↗
    ›Mar 10, 2026grant159d agoOHIO STATE UNIVERSITY — Oligosaccharide cross-feeding and competition in microbial communities

    GM grant. $375,898. PI: Darryl A Wesener

    full page →nih reporter ↗
    ›Mar 10, 2026grant159d agoUNIVERSITY OF CALIFORNIA LOS ANGELES — Intersectional analysis of the Whole Person Care-Los Angeles social care inte...University of California Los Angeles

    DK grant. $616,107. PI: Sae Takada

    full page →nih reporter ↗
    ›Mar 10, 2026grant159d agoHARVARD UNIVERSITY — Examining the processes that deform bacterial membranes to initiate cell divi...

    GM grant. $1,600,449. PI: Ethan Clark Garner

    full page →nih reporter ↗
    ›Mar 10, 2026grant159d agoVERSITI BLOOD HEALTH, INC. — Decoding kindlin-3 signaling in platelets and neutrophils

    HL grant. $1,069,072. PI: Yan-Qing Ma

    full page →nih reporter ↗
    ›Mar 10, 2026grant159d agoUNIVERSITY OF MISSOURI KANSAS CITY — Addressing Food Access and Physcial Activity to Improve Diabetes Prevention O...

    DK grant. $847,068. PI: JENIFER ELIZABETH ALLSWORTH

    full page →nih reporter ↗
    ›Mar 10, 2026grant159d agoDUKE UNIVERSITY — Real-Time, Longitudinal, Functional Brain Imaging via 4D Smart Epidermal Phot...Duke University

    EB grant. $722,392. PI: Xiaoyue Ni

    full page →nih reporter ↗
    ›Mar 10, 2026grant159d agoGORDON RESEARCH CONFERENCES — 2026 Autophagy in Stress, Development and Disease Gordon Research Conference ...

    CA grant. $4,000. PI: Rushika Miriam Perera

    full page →nih reporter ↗
    ›Mar 11, 2026approval158d agoLABETALOL HYDROCHLORIDE — FDA approvalHikma Pharmaceuticals USA Inc

    Sponsor: HIBROW HLTHCARE. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 11, 2026approval158d agoTESTOSTERONE — FDA approvalTransdermal Delivery Solutions Corp

    Sponsor: ENCUBE. Form: GEL, METERED. Route: TRANSDERMAL

    full page →fda approvals ↗
    ›Mar 11, 2026approval158d agoDOXYCYCLINE — FDA approvaldoxycycline ER

    Sponsor: STRIDES PHARMA INTL. Form: CAPSULE. Route: ORAL

    full page →doxycycline ER →fda approvals ↗
    ›Mar 11, 2026approval158d agoCEVIMELINE HYDROCHLORIDE — FDA approvalCEVIMELINE HYDROCHLORIDE

    Sponsor: ZYDUS LIFESCIENCES. Form: CAPSULE. Route: ORAL

    full page →CEVIMELINE HYDROCHLORIDE →fda approvals ↗
    ›Mar 11, 2026approval158d agoLIRAGLUTIDE — FDA approvalSaxenda

    Sponsor: BIOCON PHARMA. Form: SOLUTION. Route: SUBCUTANEOUS

    full page →Saxenda →fda approvals ↗
    ›Mar 11, 2026approval158d agoOMEPRAZOLE — FDA approvalomeprazole DR

    Sponsor: DEXCEL. Form: TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE. Route: ORAL

    full page →omeprazole DR →fda approvals ↗
    ›Mar 11, 2026approval158d agoSODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (SODIUM CHLORIDE) — FDA approvalRevalesio Corp

    Sponsor: LABORATORIOS GRIFOLS. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Mar 11, 2026approval158d agoFENOFIBRIC ACID (CHOLINE FENOFIBRATE) — FDA approvalcholine fenofibrate

    Sponsor: ALEMBIC. Form: CAPSULE, DELAYED RELEASE. Route: ORAL

    full page →choline fenofibrate →fda approvals ↗
    ›Mar 11, 2026approval158d agoFENOFIBRIC ACID (CHOLINE FENOFIBRATE) — FDA approvalcholine fenofibrate

    Sponsor: ALEMBIC. Form: CAPSULE, DELAYED RELEASE. Route: ORAL

    full page →choline fenofibrate →fda approvals ↗
    ›Mar 11, 2026approval158d agoOZURDEX (DEXAMETHASONE) — FDA approvaldexamethasone LA

    Sponsor: ABBVIE. Form: IMPLANT. Route: INTRAVITREAL

    full page →dexamethasone LA →fda approvals ↗
    ›Mar 11, 2026approval158d agoLANSOPRAZOLE — FDA approvallansoprazole DR

    Sponsor: DEXCEL. Form: TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE. Route: ORAL

    full page →lansoprazole DR →fda approvals ↗
    ›Mar 11, 2026approval158d agoFERRIC CITRATE — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: TEVA PHARMS USA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 11, 2026approval158d agoMEROPENEM — FDA approvalMEROPENEM

    Sponsor: SAVIOR LIFETEC CORP. Form: INJECTABLE. Route: INJECTION

    full page →MEROPENEM →fda approvals ↗
    ›Mar 11, 2026approval158d agoMEROPENEM — FDA approvalMEROPENEM

    Sponsor: SAVIOR LIFETEC CORP. Form: INJECTABLE. Route: INJECTION

    full page →MEROPENEM →fda approvals ↗
    ›Mar 11, 2026approval158d agoMEROPENEM — FDA approvalMEROPENEM

    Sponsor: SAVIOR LIFETEC CORP. Form: INJECTABLE. Route: INJECTION

    full page →MEROPENEM →fda approvals ↗
    ›Mar 11, 2026approval158d agoLINAGLIPTIN AND METFORMIN HYDROCHLORIDE (LINAGLIPTIN) — FDA approvalZydus Therapeutics Inc

    Sponsor: ZYDUS PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 11, 2026approval158d agoAPHEXDA (MOTIXAFORTIDE ACETATE) — FDA approvalBioLineRx Ltd.

    Sponsor: AYRMID PHARMA. Form: POWDER. Route: SUBCUTANEOUS

    full page →fda approvals ↗
    ›Mar 11, 2026approval158d agoBRIMONIDINE TARTRATE — FDA approvalLumify

    Sponsor: GLAND. Form: SOLUTION/DROPS. Route: OPHTHALMIC

    full page →Lumify →fda approvals ↗
    ›Mar 11, 2026recall158d agoCipla USA, Inc. recall (Cls III)Cipla USA Inc

    Nilotinib Capsules, 150 mg per capsule, packaged in cartons, Rx only, Manufactured by: Cipla Ltd., Verna, Goa, India, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, Outer carton: 112 capsules (4 individual packs containing 28 capsules each) NDC 69097-031-74; Inner carton: 28 capsules (4 blisters of 7 capsules) NDC 69097-031-56; Foil blister: NDC 69097-031-17 — Reason: Failed Tablet/Capsule Specifications: Observed OOS results at 6-months long-term stability condition for Description test and Appearance by Visual Inspection test. — Status: Ongoing

    full page →fda recalls ↗
    ›Mar 11, 2026recall158d agoACME UNITED CORPORATION recall (Cls II)ACME UNITED CORP

    Med Nap BZK Antiseptic Towelettes (Benzalkonium Chloride 0.13%), 100 Towelettes, Manufactured by: Acme United Corporation, 1 Waterview Dr, Shelton, CT 06481, NDC 0924-0246-01. — Reason: CGMP Deviations — Status: Ongoing

    full page →fda recalls ↗
    ›Mar 11, 2026recall158d agoACME UNITED CORPORATION recall (Cls II)ACME UNITED CORP

    Dynarex, BZK Antiseptic Towelettes (Benzalkonium Chloride 0.13%), 5x7, 1000 packets, 5x7, Manufactured for Dynarex Corporation, 10 Glenshaw Street, Orangeburg, NY 10962,USA, NDC 67777-245-04. — Reason: CGMP Deviations — Status: Ongoing

    full page →fda recalls ↗
    ›Mar 11, 2026recall158d agoThe Harvard Drug Group LLC recall (Cls II)Novugen Pharma (Malaysia) Sdn Bhd

    Midodrine Hydrochloride Tablets, USP, 5 mg, 50 Tablets (5 x 10 blister packs), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268 USA, NDC 0904-6818-06. — Reason: Defective container; inadequately sealed blister packaging. — Status: Ongoing

    full page →fda recalls ↗
    ›Mar 11, 2026recall158d agoHarbin Jixianglong Biotech Co., Ltd. recall (Cls II)Novo Nordisk AS

    Semaglutide, For Rx compounding use only, packaged in a) 1g, NDC 84385-106-01; b) 5g, NDC 84385-106-02; c) 10g, NDC 84385-106-06; d) 25g, NDC 84385-106-03; d) 50g, NDC 84385-106-04; e) 100g, NDC 84385-106-05Manufacturer: Harbin Jixianglong Biotech Co., Ltd., North of Baoan Road, East of Changqing Street, Limin Development Zone, Harbin, China. — Reason: CGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation before distribution — Status: Ongoing

    full page →fda recalls ↗
    ← prev
    page 18 of 160
    next →
    $BLRX2.7600+1.52%
    $ACU45.90-1.54%
    $ACU45.90-1.54%
    $ABBV249.46-0.54%